Brief: Melodiol Global Health Says A$2.13 Mln In Unaudited Revenue For Q4 FY23
16/01/2024 05:22
Jan 16 (Reuters) - Melodiol Global Health Ltd ME1.AX :
* MERNOVA REVENUE UPDATE AND PLACEMENT
* A$2.13M IN UNAUDITED REVENUE GENERATED IN Q4 FY2023, MARKS
15%
RISE ON Q3
Source text for Eikon: ID:nASX79WChB
Further company coverage: ME1.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Melodiol Global Health
See all newsBrief: Melodiol Global Health Reports Q1 Fy24 Unaudited Revenue Of A$4.8M
Brief: Melodiol Global Health Posts Group Unaudited H1 2024 Revenues Of A$9.3 Mln, Up 33%
Brief: Melodiol Global Health Seeks Trading Halt
Melodiol Global Health gains most in over 7 weeks on Canada asset sale
Brief: Melodiol Global Health Proposes A$12M Cash Asset Sale